COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Centers for Disease Control and Prevention released a report describing the characteristics of multisystem inflammatory syndrome (MIS-C), a rare but serious condition that states have reported in more than 500 children with COVID-19.
The Food and Drug Administration Tuesday authorized the emergency use of three types of ventilator accessories for treating COVID-19 patients.
The Centers for Medicare & Medicaid Services does not intend for Paycheck Protection Program funds to impact Medicare payments to rural hospitals, CMS Administrator Seema Verma said in a tweet.
Health care facilities or providers facing inadequate supplies of certain drugs needed to treat patients with COVID-19 should not use the products more than four hours beyond the labeled “in-use time” for refrigerated storage or two hours beyond the labeled “in-use time” for room temperature…
The National Institutes of Health announced clinical trials to investigate the safety and efficacy of a synthetic antibody therapy in COVID-19 patients.
The Centers for Medicare & Medicaid Services will allow health insurers to offer premium reductions for individuals with 2020 coverage in the individual and small group markets when consistent with state law, the agency announced.
The American Hospital Association (AHA) urges the Centers for Medicare & Medicaid Services (CMS) to allow periodic interim payment (PIP) hospitals to carry out their accelerated payment repayment at cost settlement, as was initially communicated by the agency. We also request that the agency…
The Department of Health and Human Services updated its guidance and FAQs regarding the agency’s request for daily COVID-19-related hospital data reporting.
The Centers for Disease Control and Prevention Aug. 3 at 3 p.m. ET will hold a webinar with updates on the COVID-19 response, including new resources for businesses and other private-sector organizations.
A study released by the Centers for Disease Control and Prevention demonstrates that SARS-CoV-2 spreads efficiently in youth-centric settings, resulting in high attack rates among persons in all age groups.